Table 5.
Summary of the interference studies. Known concentrations of interferent were spiked into a known nonreactive or reactive sample.
| Sample | Interferant | % Difference to control IgG | % Difference to control IgM |
|---|---|---|---|
| Negative sample |
Hemolysate 120 mg/dL |
3.30 | −6.50 |
| Conjugated bilirubin 30 g/dL | −8.40 | 12.70 | |
| Triglyceride-rich lipid 250 mg/dL | 4.80 | 34.30 | |
| Biotin (10,000 ng/ml) | 38.98 | 7.90 | |
| Positive sample | Hemolysate 120 mg/dL |
7.28 | −5.00 |
| Conjugated bilirubin 30 g/dL | 9.47 | 4.30 | |
| Triglyceride-rich lipid 250 mg/dL | 13.81 | 1.20 | |
| Biotin (10,000 ng/ml) | −6.31 | −5.92 |